Showing 2441-2450 of 2812 results for "".
- Meet Derma V, the new workstation from Lutronichttps://modernaesthetics.com/news/meet-derma-v-the-new-workstation-from-lutronic/2473157/Lutronic is launching Derma V, a dermatology workstation that comprises a 532nm green laser, a 1064nm laser plus ICD cooling and IntelliTrack. "We created a device that brings the essential lasers that skin specialists need for their daily work - vascular, pigment and rejuvenation
- Alastin Receives Two New Patents for Technology Related to TransFORM Body Treatmenthttps://modernaesthetics.com/news/alastin-receives-two-new-patents-for-technology-related-to-transform-body-treatment/2473148/With the issuance of two new patents from the United States Patent and Trademark Office, Alastin Skincare, Inc. now holds six patents in the US, along with a seventh patent issued in Canada. US Patent No.11,052,032 covers Alastin’s
- Galderma's Restylane Turns 25!https://modernaesthetics.com/news/galdermas-restylane-turns-25/2473147/Galderma’s Restylane is celebrating 25 years on the market. Since launching in Europe in 1996, Restylane has celebrated many milestones across the globe. This includes the first approval for use by the U.S. Food and Drug Administration (FDA) in 2003 and in China by the Nation
- It’s Over: AbbVie, BTL Settle Muscle Stimulation Patent Disputehttps://modernaesthetics.com/news/its-over-abbvie-btl-settle-patent-dispute/2473143/BTL Industries has resolved its patent infringement claims against AbbVie related to BTL's muscle stimulation technology. Under the terms of the settlement agreement, AbbVie will pay BTL an undisclosed payment. The details of the agreement are confidential and will not be disc
- Sientra’s Allox2 Helps Manage Seroma and Infection in Prepectoral Breast Reconstructionhttps://modernaesthetics.com/news/sientras-allox2s-helps-manage-seroma-and-infection-in-prepectoral-breast-reconstruction/2473138/The Sientra Allox2 dual port tissue expander enables efficient management of seroma and early targeted intervention in prepectoral breast reconstruction, according to a new study on PRS Global Open. Seroma are among the most common complications after staged prepectoral implant
- As Aging Population Increases, Medical Aesthetics Market is Predicted to Growhttps://modernaesthetics.com/news/as-aging-population-increases-medical-aesthetics-market-is-predicted-to-grow/2473135/The global Medical Aesthetics Market, valued at USD 10.1 billion in 2018, is expected to reach USD 20.4 billion in 2026, growing at a CAGR of 9.0% during the forecast period, according to the latest report from All
- Elite World Group Taps Elysium Health to Develop Science-First Skincare Linehttps://modernaesthetics.com/news/elite-world-group-taps-leading-elysium-health-to-develop-science-first-skincare-line/2473133/Elysium Health, Inc. is joining forces with Elite World Group to develop a line of skincare products. Launching in spring 2022, the line is currently in development and will be sold under an independent trademark. Elite World Group's talent media network, paired wit
- San Francisco Plastic Surgery Practice Mandates Vaccines for Staff and Patientshttps://modernaesthetics.com/news/san-francisco-plastic-surgery-practice-mandates-vaccines-for-staff-and-patients/2473131/Jonathan Kaplan, MD has instituted a new policy for his Pacific Heights Plastic Surgery practice in San Francisco. All staff and patients are now required to have had the COVID-19 vaccine to enter the practice. As was recently reported in
- Bausch Health Pursues IPO of Solta Medicalhttps://modernaesthetics.com/news/bausch-health-pursues-ipo-of-solta-medical/2473130/Bausch Health Companies Inc. is planning to pursue an initial public offering (IPO) of its Solta Medical business. Solta’s portfolio includes the Thermage RF systems, Fraxel laser, Clear + Brilliant laser and VASER ultrasonic systems. The timing of the anticipated IPO, w
- Alma Hybrid Launcheshttps://modernaesthetics.com/news/alma-hybrid-launches/2473128/Alma Hybrid™, the first laser platform to include an ablative 10,600nm (CO2) laser and a non-ablative 1570nm laser for skin resurfacing, in launching in the US. The system received FDA 510(k) clearance. Alma Hybrid offers p